Weight-loss medications such as GLP-1 receptor agonists—including well-known names like Ozempic and Zepbound—have rapidly gained recognition for their ability to help users shed significant pounds. Yet, despite their remarkable efficacy, experts from leading healthcare institutions caution that medication alone is insufficient. Achieving sustainable weight loss and avoiding adverse effects requires a comprehensive approach that integrates …
Continue reading “Experts suggest integrating healthy lifestyle adjustments with GLP-1 medication”